| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |